Bristol-Myers Squibb Company Financial Ratios — BRM.DE Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	11.39	5.92	7.75	6.08	4.85	13.6	3.09	14.98	9.96	-32	30.62	25.36	29.26	-40.43	43.55
Return on Assets (%)	11.58	5.69	6.88	5.54	4.78	13.62	2.99	14.36	4.17	-7.26	6.14	6.14	8.36	-9.53	7.72
Return on Capital (%)	5.97	- -	6.65	5.23	4.14	11.44	2.69	12.43	6.24	- -	11.36	10.74	13.3	- -	12.97
Return on Invested Capital (%)	23.52	- -	11.69	6.26	6.1	15.51	3.06	20.59	4.92	- -	8.64	9.75	10.86	- -	15.61
Gross Margin (%)	73.65	73.84	71.81	75.24	76.39	74.42	71.05	71.34	69.1	72.31	78.57	78.04	76.24	71.08	71.08
EBITDA Margin (%)	34.2	26.18	22.55	13.74	12.72	25.33	20.39	25.61	23.18	29.56	41.44	41.99	39.89	32.06	36.8
Operating Margin (%)	31.24	22.31	17.89	10.79	10.45	23.36	16.59	22.79	16.5	5.15	18.4	19.72	18.21	12.19	28.48
Incremental Operating Margin (%)	39.03	74.66	80.99	240.51	2.35	97.98	-80.95	94.9	-23.07	-12.97	164.13	-250.88	78.84	-70.07	-7,463.81
Pretax Margin (%)	32.86	13.28	17.64	14.99	12.54	30.45	24.7	26.45	19.03	-16.16	17.46	16.71	18.75	-17.35	19.35
Profit Margin (%)	17.46	11.12	15.64	12.62	9.45	22.94	4.85	21.81	13.15	-21.2	15.08	13.71	17.83	-18.53	14.64
Net Income to Common Margin (%)	17.46	11.12	15.64	12.62	9.45	22.94	4.85	21.81	13.15	-21.2	15.08	13.71	17.83	-18.53	14.64
Effective Tax Rate (%)	24.65	- -	10.76	14.78	21.47	23.8	81	17.11	30.45	- -	13.39	17.74	4.74	- -	24.36
Dvd Payout Ratio (%)	33.09	75.15	88.91	116.75	145.96	55.89	273.28	52.53	76.96	-45.4	62.5	72.83	58.9	-54.53	71.49
Sustainable Growth Rate (%)	7.62	1.47	0.86	-1.02	-2.23	6	-5.36	7.11	2.29	-46.53	11.48	6.89	12.03	-62.48	12.42

Credit (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	5,491	7,394	8,340	7,832	6,689	6,708	7,962	7,349	47,538	51,673	45,596	40,717	41,464	51,200	47,139
ST Debt	115	826	359	590	139	992	987	1,703	3,479	2,504	5,117	4,400	3,281	2,227	2,463
LT Debt	5,376	6,568	7,981	7,242	6,550	5,716	6,975	5,646	44,059	49,169	40,479	36,317	38,183	48,973	44,676
Total Debt/EBITDA	0.76	1.6	2.26	3.59	3.18	1.36	1.88	1.27	7.84	4.11	2.37	2.1	2.31	3.31	2.66
Net Debt/EBITDA	-0.04	1.24	1.29	1.04	2.04	0.5	0.6	0.08	5.67	2.87	1.59	1.56	1.58	2.54	1.97
Total Debt/EBIT	0.83	1.88	2.85	4.57	3.87	1.48	2.31	1.43	11.02	23.59	5.34	4.47	5.06	8.7	3.43
Net Debt/EBIT	-0.04	1.46	1.62	1.32	2.49	0.54	0.74	0.09	7.97	16.5	3.58	3.32	3.45	6.68	2.54
EBITDA to Interest Expense	50.1	25.35	18.56	10.74	11.45	29.47	21.61	31.57	9.24	8.85	14.41	15.73	15.4	7.95	9.38
EBITDA-CapEx/Interest Expense	47.57	22.34	15.86	8.15	11.45	29.47	21.61	31.57	9.24	8.85	14.41	15.73	15.4	7.95	9.38
EBIT to Interest Expense	45.77	21.6	14.73	8.44	9.4	27.18	17.59	28.09	6.58	1.54	6.4	7.39	7.03	3.02	7.26
Interest Expense	145	182	199	203	184	167	196	183	656	1,420	1,334	1,232	1,166	1,947	1,891
Common Equity/Total Assets	100.97	91.8	85.96	97.08	100.27	100.08	93.53	98	26.75	18.21	22.06	26.64	30.54	16.42	19.09
Long-Term Debt/Equity (%)	33.88	48.16	52.38	48.33	45.41	34.97	58.88	39.97	85.22	129.8	112.42	116.71	129.5	298.83	241.41
Long-Term Debt/Capital (%)	13.89	16.27	19.19	17.78	16.93	14.07	17.68	13.53	53.47	67.07	58.02	54.56	54.1	73.69	69.42
Long-Term Debt/Total Assets (%)	16.31	18.3	20.68	21.46	20.63	16.96	20.79	16.14	33.91	41.5	37.03	37.51	40.13	52.88	49.62
Total Debt/Equity (%)	34.61	54.22	54.74	52.27	46.37	41.04	67.21	52.02	91.95	136.41	126.63	130.85	140.63	312.42	254.72
Total Debt/Capital (%)	14.19	18.32	20.05	19.23	17.29	16.52	20.18	17.61	57.69	70.49	65.35	61.17	58.75	77.04	73.24
Total Debt/Total Assets (%)	16.65	20.6	21.61	23.21	21.07	19.9	23.73	21.01	36.58	43.61	41.71	42.05	43.57	55.29	52.35
Net Debt to Equity	-1.8	42.07	31.2	15.09	29.84	15.12	21.45	3.1	66.52	95.38	84.91	97.04	96.01	239.83	188.6
Net Debt/Capital (%)	-0.87	14.82	12.51	6.43	11.86	6.79	7.47	1.26	49.08	61.49	54.8	52.57	47.89	70.05	64.45
EBITDA	7,265	4,613	3,694	2,181	2,106	4,921	4,236	5,778	6,060	12,570	19,223	19,380	17,955	15,487	17,735
EBITDA-CapEx	6,898	4,065	3,157	1,655	2,106	4,921	4,236	5,778	6,060	12,570	19,223	19,380	17,955	15,487	17,735
Operating Income (Loss)	6,637	3,932	2,931	1,714	1,730	4,539	3,447	5,141	4,314	2,190	8,537	9,104	8,195	5,887	13,724

Liquidity (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	1.12	0.34	0.36	0.88	0.53	0.72	0.71	0.82	0.84	0.86	0.79	0.42	0.55	0.46	0.46
Current Ratio	1.97	1.15	1.52	1.73	1.3	1.55	1.55	1.66	1.6	1.58	1.52	1.25	1.43	1.25	1.26
Quick Ratio	1.6	0.71	0.63	1.28	1.07	1.35	1.37	1.36	1.26	1.42	1.36	1.06	1.24	1.06	1.08
CFO/Avg Current Liab	0.67	0.86	0.34	0.3	0.26	0.36	0.57	0.7	0.57	0.75	0.79	0.6	0.63	0.66	0.6
Common Equity/Total Assets	100.97	91.8	85.96	97.08	100.27	100.08	93.53	98	26.75	18.21	22.06	26.64	30.54	16.42	19.09
Long-Term Debt/Equity (%)	33.88	48.16	52.38	48.33	45.41	34.97	58.88	39.97	85.22	129.8	112.42	116.71	129.5	298.83	241.41
Long-Term Debt/Capital (%)	13.89	16.27	19.19	17.78	16.93	14.07	17.68	13.53	53.47	67.07	58.02	54.56	54.1	73.69	69.42
Long-Term Debt/Total Assets (%)	16.31	18.3	20.68	21.46	20.63	16.96	20.79	16.14	33.91	41.5	37.03	37.51	40.13	52.88	49.62
Total Debt/Equity (%)	34.61	54.22	54.74	52.27	46.37	41.04	67.21	52.02	91.95	136.41	126.63	130.85	140.63	312.42	254.72
Total Debt/Capital (%)	14.19	18.32	20.05	19.23	17.29	16.52	20.18	17.61	57.69	70.49	65.35	61.17	58.75	77.04	73.24
Total Debt/Total Assets (%)	16.65	20.6	21.61	23.21	21.07	19.9	23.73	21.01	36.58	43.61	41.71	42.05	43.57	55.29	52.35
CFO/Total Liabilities	28.3	31.18	15.18	16.78	12.15	17.62	24.3	33.88	10.49	17.43	22.11	19.89	21.1	19.93	19.79
CFO/CapEx	13.19	12.67	6.6	5.98	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Altman's Z-Score	5.68	5.43	5.01	6.18	6.96	6.81	6.04	5.88	3.18	3.12	3.74	4.42	3.63	2.94	3.46

Working Capital (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	18.88	8.9	9.64	8.38	6.56	5.78	5.12	5.02	4.71	6.21	6.1	5.72	5.28	5.4	5.18
Days Sales Outstanding	19.33	40.99	37.85	43.56	55.63	63.15	71.34	72.67	77.57	58.78	59.8	63.77	69.07	67.61	70.45
Inventory Turnover	4.33	3.03	2.93	2.57	2.81	4.04	5	5.48	2.94	3.7	4.77	4.57	4.28	5.35	5.31
Days Inventory Outstanding	84.37	120.39	124.66	141.93	129.84	90.42	73.04	66.63	123.99	98.7	76.54	79.83	85.35	68.19	68.71
Accounts Payable Turnover	2.52	2.03	1.87	1.58	1.76	3.09	3.04	3.14	5.15	3.7	3.52	3.47	3.5	4.04	3.92
Accounts Payable Turnover Days	144.85	179.58	194.82	230.57	207.14	118.12	120.21	116.31	70.82	98.53	103.74	105.29	104.35	90.32	93.1
Cash Conversion Cycle	-41.15	-18.21	-32.31	-45.08	-21.67	35.45	24.17	22.98	130.73	58.95	32.6	38.31	50.07	45.48	46.06
Inventory to Cash Days	-65.04	-79.39	-86.81	-98.38	-74.21	-27.28	-1.71	6.04	-46.42	-39.92	-16.75	-16.05	-16.28	-0.58	1.74
Inventories	1,384	1,657	1,498	1,560	1,221	1,241	1,166	1,195	4,293	2,074	2,095	2,339	2,662	2,557	2,690
Raw Materials	260	271	250	204	199	264	273	116	172	207	350	464	- -	- -	- -
Work In Process	646	814	757	856	868	988	931	1,152	3,267	2,015	2,111	1,850	- -	- -	- -
Finished Goods	478	572	491	500	381	310	384	356	2,227	932	543	509	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	-1,080	-909	-484	2,662	2,557	2,690

Enterprise Value (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	46,264	53,241	88,470	100,008	115,531	97,943	101,919	82,966	109,425	139,090	134,278	154,674	105,962	116,352	109,919
- Cash & Cash Equivalents	5,776	1,656	3,586	5,571	2,385	4,237	5,421	6,911	12,346	14,546	13,979	9,123	11,464	10,346	10,209
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	-89	15	82	131	158	170	106	96	100	60	60	57	55	53	33
+ Total Debt	5,491	7,394	8,340	7,832	6,689	6,708	7,962	7,349	47,538	51,673	45,596	40,717	41,464	51,200	47,139
Enterprise Value	42,933	57,821	92,367	100,536	118,108	98,471	103,175	81,652	141,670	174,373	162,713	186,195	135,201	156,746	146,418
Total Capital	38,691	40,363	41,595	40,725	38,681	40,612	39,449	41,731	82,404	73,306	69,768	66,569	70,577	66,457	64,360
Total Debt/Capital (%)	14.19	18.32	20.05	19.23	17.29	16.52	20.18	17.61	57.69	70.49	65.35	61.17	58.75	77.04	73.24
Total Debt / EV	0.13	0.13	0.09	0.08	0.06	0.07	0.08	0.09	0.34	0.3	0.28	0.22	0.31	0.33	0.32
EV/Sales	2.02	3.28	5.64	6.33	7.13	5.07	4.97	3.62	5.42	4.1	3.51	4.03	3	3.25	3.04
EV/EBITDA	5.91	12.53	25	46.1	56.08	20.01	24.36	14.13	23.38	13.87	8.46	9.61	7.53	10.12	8.26
EV/EBIT	6.47	14.71	31.51	58.66	68.27	21.69	29.93	15.88	32.84	79.62	19.06	20.45	16.5	26.63	10.67
EV/Cash Flow to Firm	8.67	8.1	24.81	30.27	52.5	30.91	19.42	11.31	16.35	10.96	9.37	13.22	9.03	9.08	9.39
EV/Free Cash Flow to Firm	8.08	7.53	21.68	26.13	52.5	30.91	19.42	11.31	16.35	10.96	9.37	13.22	9.03	9.08	9.39
Diluted Market Cap	46,727	53,815	89,439	100,793	116,362	98,471	102,353	83,169	109,874	139,090	140,015	155,836	106,423	116,352	110,189
Diluted Enterprise Value	46,353	59,568	94,275	103,185	120,824	101,112	105,000	83,703	145,166	176,277	171,692	187,487	136,478	157,259	147,152
EV per Share	25.25	34.62	56.18	60.67	70.85	58.93	62.72	50	83.09	77.22	75.57	87.42	65.35	77.33	71.99
TTM Sales	21,244	17,621	16,385	15,879	16,560	19,427	20,776	22,561	26,145	42,518	46,385	46,159	45,006	48,300	48,195
TTM EBITDA	7,265	4,613	3,694	2,181	2,106	4,921	4,236	5,778	6,060	12,570	19,223	19,380	17,955	15,487	17,735
TTM Operating Income	6,637	3,932	2,931	1,714	1,730	4,539	3,447	5,141	4,314	2,190	8,537	9,104	8,195	5,887	13,724
TTM Cash Flow to Firm	4,949	7,136	3,723	3,321	2,249	3,185	5,312	7,218	8,666	15,911	17,362	14,079	14,971	17,266	15,586
TTM Free Cash Flow to Firm	5,316	7,684	4,260	3,847	2,249	3,185	5,312	7,218	8,666	15,911	17,362	14,079	14,971	17,266	15,586

Multiples (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	8.97	7.19	21.91	27.43	55.28	32.2	19.4	11.77	13.38	9.9	8.64	11.93	7.68	7.66	7.78
EV/EBIT	6.47	14.71	31.51	58.66	68.27	21.69	29.93	15.88	32.84	79.62	19.06	20.45	16.5	26.63	10.67
Enterprise Value	42,933	57,821	92,367	100,536	118,108	98,471	103,175	81,652	141,670	174,373	162,713	186,195	135,201	156,746	146,418
Low Price	25.17	26.6	31.47	46.55	57.32	49.24	46.98	47.62	41.88	45.5	53.73	60.81	48.36	39.47	42.43
EV/Sales	2.02	3.28	5.64	6.33	7.13	5.07	4.97	3.62	5.42	4.1	3.51	4.03	3	3.25	3.04
EV/EBITDA	5.91	12.53	25	46.1	56.08	20.01	24.36	14.13	23.38	13.87	8.46	9.61	7.53	10.12	8.26
Price/Earnings	12.47	27.16	34.52	49.9	73.82	21.98	101.21	16.86	31.82	- -	19.2	24.45	13.2	- -	15.58
Price/Earnings Average	12.85	27.85	28.03	43.05	68.71	23.7	94.07	19.2	24.8	-15.22	19.42	24.51	16.2	-11.22	14.54
Price/Earnings High	14.14	30.96	34.65	51.64	76.05	28.96	107.35	23.15	32.2	-17.1	21.48	27.57	19.33	-14.07	18.23
Price/Earnings Low	11.54	22.66	20.19	38.49	61.05	18.46	76.75	15.81	20.76	-11.4	16.54	20.47	12.47	-8.94	12.24
Price/Book Value	1.39	1.62	2.67	3.05	3.63	2.9	3.25	2.42	3.15	6.45	5.57	6	3.65	7.65	6.4
Price/Book Value Average	1.43	1.66	2.17	2.63	3.38	3.13	3.02	2.75	2.45	6.36	5.63	6.01	4.47	6.6	5.97
Price/Book Value High	1.58	1.84	2.68	3.16	3.74	3.83	3.44	3.32	3.19	7.15	6.23	6.76	5.34	8.28	7.48
Price/Book Value Low	1.29	1.35	1.56	2.35	3	2.44	2.46	2.27	2.05	4.76	4.8	5.02	3.44	5.26	5.02
Price/Tangible Book Value	6.46	-19.19	15.2	16.12	18.87	12.11	27.01	12.77	-3.15	-3.85	-4.92	-5.86	-5.53	-4.02	-4.86
Price/Tangible Book Value Average	6.66	-19.67	12.34	13.91	17.56	13.06	25.1	14.54	-2.45	-3.8	-4.98	-5.88	-6.78	-3.46	-4.54
Price/Tangible Book Value High	7.33	-21.87	15.25	16.68	19.44	15.96	28.64	17.53	-3.19	-4.27	-5.51	-6.61	-8.09	-4.34	-5.69
Price/Tangible Book Value Low	5.98	-16.01	8.89	12.43	15.6	10.17	20.48	11.97	-2.05	-2.84	-4.24	-4.91	-5.22	-2.76	-3.82
Price/Sales	2.18	3.02	5.4	6.3	6.98	5.04	4.91	3.68	4.19	3.27	2.89	3.35	2.35	2.41	2.28
Price/Sales Average	2.24	3.1	4.38	5.43	6.49	5.44	4.56	4.19	3.26	3.23	2.93	3.36	2.89	2.08	2.13
Price/Sales High	2.47	3.44	5.42	6.52	7.19	6.64	5.2	5.05	4.24	3.63	3.24	3.78	3.45	2.61	2.67
Price/Sales Low	2.01	2.52	3.16	4.86	5.77	4.24	3.72	3.45	2.73	2.42	2.49	2.81	2.22	1.66	1.79
Price/Cash Flow	9.56	7.67	24.96	31.77	54.88	32.03	19.32	11.74	13.33	9.9	8.29	11.84	7.65	7.66	7.76
Price/Cash Flow Average	9.85	7.86	20.26	27.4	51.09	34.54	17.96	13.37	10.39	9.76	8.38	11.87	9.38	6.61	7.24
Price/Cash Flow High	10.84	8.74	25.05	32.87	56.54	42.2	20.49	16.12	13.49	10.97	9.27	13.35	11.19	8.29	9.08
Price/Cash Flow Low	8.84	6.4	14.6	24.5	45.39	26.91	14.65	11.01	8.7	7.31	7.14	9.91	7.22	5.27	6.1
Price/Free Cash Flow Average	9.25	7.37	17.79	23.66	51.45	34.73	18.04	13.4	10.43	9.76	8.74	11.96	9.42	6.61	7.26
Price/Free Cash Flow High	10.17	8.19	21.99	28.39	56.95	42.43	20.58	16.16	13.54	10.97	9.67	13.45	11.24	8.29	9.11
Price/Free Cash Flow Low	8.3	6	12.81	21.16	45.72	27.05	14.71	11.03	8.73	7.31	7.44	9.99	7.25	5.27	6.11
EV/Sales Average	2.23	3.42	4.68	5.58	6.76	5.57	4.69	4.21	4.61	4.1	3.61	4.04	3.56	2.93	2.89
EV/Sales High	2.45	3.77	5.71	6.67	7.46	6.78	5.33	5.07	5.59	4.5	3.92	4.46	4.12	3.45	3.43
EV/Sales Low	2	2.85	3.45	5.01	6.04	4.37	3.85	3.47	4.08	3.29	3.18	3.49	2.89	2.5	2.56
EV/EBITDA Average	6.51	13.08	20.76	40.65	53.18	22	22.99	16.44	19.9	13.87	8.71	9.63	8.92	9.12	7.87
EV/EBITDA High	7.17	14.4	25.35	48.55	58.63	26.76	26.15	19.8	24.1	15.22	9.46	10.63	10.32	10.77	9.33
EV/EBITDA Low	5.84	10.88	15.32	36.46	47.49	17.26	18.87	13.55	17.61	11.13	7.67	8.32	7.25	7.81	6.95
EV/EBIT Average	7.12	15.34	26.16	51.72	64.74	23.85	28.25	18.48	27.95	79.61	19.62	20.51	19.53	24	10.17
EV/EBIT High	7.85	16.9	31.95	61.77	71.38	29.02	32.13	22.26	33.85	87.37	21.31	22.64	22.6	28.33	12.06
EV/EBIT Low	6.39	12.76	19.3	46.39	57.81	18.71	23.19	15.23	24.73	63.9	17.26	17.7	15.88	20.54	8.98
Last Price	27.21	31.88	53.81	60.35	69.3	58.61	61.96	50.81	64.18	61.6	62.37	72.62	51.21	57.4	54.04
High Price	30.85	36.34	54.02	62.46	71.4	77.24	65.72	69.74	64.95	68.27	69.79	81.89	74.99	62.1	63.22
Enterprise Value Average	47,289	60,333	76,674	88,656	111,999	108,267	97,379	94,987	120,582	174,351	167,474	186,709	160,084	141,279	139,516
Enterprise Value High	52,073	66,434	93,639	105,880	123,485	131,701	110,751	114,418	146,034	191,350	181,937	206,082	185,212	166,794	165,544
Enterprise Value Low	42,423	50,171	56,577	79,520	100,012	84,917	79,935	78,302	106,694	139,930	147,361	161,180	130,102	120,918	123,272

Shares Outstanding	1,685	1,630	1,641	1,653	1,661	1,664	1,625	1,624	2,228	2,221	2,153	2,075	2,021	2,029	2,036
Diluted Weighted Avg Shares	1,717	1,688	1,662	1,670	1,679	1,680	1,652	1,637	1,712	2,258	2,245	2,146	2,078	2,027	2,039
Basic Weighted Avg Shares	1,700	1,670	1,644	1,657	1,667	1,671	1,645	1,633	1,705	2,258	2,153	2,130	2,069	2,027	2,034
Revenue per Share	12.5	10.55	9.97	9.58	9.93	11.63	12.63	13.82	15.33	18.83	21.54	21.67	21.75	23.83	23.69
EBITDA per Share	4.27	2.76	2.25	1.32	1.26	2.94	2.58	3.54	3.55	5.57	8.93	9.1	8.68	7.64	8.72
Operating Income per Share	3.9	2.35	1.78	1.03	1.04	2.72	2.1	3.15	2.53	0.97	3.97	4.27	3.96	2.9	6.75
Basic EPS, GAAP	2.18	1.17	1.56	1.21	0.94	2.67	0.61	3.01	2.02	-3.99	3.25	2.97	3.88	-4.41	3.47
Basic EPS from Cont Ops	3.09	1.5	1.57	1.22	0.98	2.7	0.59	3.03	2.03	-3.98	3.26	2.98	3.89	-4.41	3.47
Diluted EPS, GAAP	2.16	1.16	1.54	1.2	0.93	2.65	0.61	3.01	2.01	-3.99	3.12	2.95	3.86	-4.41	3.46
Diluted EPS from Cont Ops	3.06	1.48	1.55	1.21	0.97	2.68	0.59	3.02	2.02	-3.98	3.12	2.96	3.87	-4.41	3.46
Dividend per Share	1.33	1.37	1.4	1.45	1.49	1.52	1.57	1.6	1.57	1.8	2.04	2.18	2.29	2.4	2.48
Cash Flow per Share	2.85	4.16	2.16	1.9	1.26	1.83	3.21	4.33	4.82	6.22	7.53	6.13	6.7	7.49	6.96
Free Cash Flow per Basic Share	2.63	3.83	1.83	1.58	1.26	1.83	3.21	4.33	4.82	6.22	7.53	6.13	6.7	7.49	6.96
Cash & Equivalents per Share	5.14	1.69	2.75	4.49	2.56	3.8	4.14	5.36	9.03	7.29	8	4.34	5.94	5.36	5.25
Book Value per Share	19.58	19.73	20.18	19.77	19.1	20.19	19.08	21	20.39	9.55	11.2	12.11	14.04	7.5	8.45
Tangible Book Value per Share	4.21	-1.66	3.54	3.74	3.67	4.84	2.29	3.98	-20.39	-15.99	-12.67	-12.39	-9.26	-14.29	-11.11

Bristol-Myers Squibb Company

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)